Thirty years of progress in cutaneous lymphoma research

Giornale Italiano di Dermatologia e Venereologia

Volumn 147, Issue 6, 2012, Pages 515-521

  Willemze, R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Guidelines as topic; Lymphoma; Skin diseases

Indexed keywords

B CELL LYMPHOMA; CLINICAL TRIAL (TOPIC); CUTANEOUS B CELL LYMPHOMA; CUTANEOUS T CELL LYMPHOMA; DISEASE CLASSIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; MYCOSIS FUNGOIDES; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SEZARY SYNDROME; SKIN LYMPHOMA;

EID: 84874379026     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Lutzner M, Edelson R, Schein P, Green I, Kirkpatrick C, Ahmed A. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med 1975;83:534-52.
2. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S et al. EORTC Classification for primary cutaneous lymphomas. A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (EORTC). Blood 1997;90:354-71.
3. Grange F, Hedelin G, Joly P, Beylot-Barry M, D'Incan M, Delaunay M et al. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sezary syndrome. The French Study Group on Cutaneous Lymphomas. Blood 1999;93:3637-42.
4. Fink-Puches R, Zenahlik P, Back B, Smolle J, Kerl H, Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (EORTC, WHO) based on clinicopathologic features observed in a large group of patients. Blood 2002;99:800-5.
5. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-85.
6. Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S et al. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 2006;24:1376-82.
7. Senff NJ, Hoefnagel JJ, Jansen PM, Vermeer MH, van Baarlen J, Blokx WA et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007;25:1581-7.
8. Khamaysi Z, Ben-Arieh Y, Izhak OB, Epelbaum R, Dann EJ, Bergman R. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center. Am J Dermatopathol 2008;30:37-44.
9. Swerdlow A, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H et al. World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tissue. Lyon: IARC Press; 2008.
10. Grange F, Bekkenk MW, Wechsler J, Meijer CJ, Cerroni L, Bernengo M et al. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicentre study. J Clin Oncol 2001;19:3602-1610.
11. Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Muller-Hermelink HK et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003;97:610-27.
12. Assaf C, Gellrich S, Whittaker S, Robson A, Cerroni L, Massone C etal. CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol 2007;60:981-9.
13. Kempf W, Ostheeren-Michaelis S, Paulli M, Lucioni M, Wechsler J, Audring H et al. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of thr Cutaneous Lymphoma Histopathology Task Force Group of the European Organization for Research and Treatment of Cancer (EORTC). Arch Dermatol 2008;144:1609-17.
14. Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 2008; 111:838-45.
15. Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S et al. Defining early mycosis fungoides. J Am Acad Dermatol 2005;53:1053-63.
16. Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002;46:95-106.
17. Jones GW, Kacinski BM, Wilson LD, Willemze R, Spittle M, Hohenberg G et al. Total skin electron beam irradiation in the management of mycosis fungoides: consensus of the EORTC Cutaneous Lymphoma Project Group. J Am Acad Dermatol 2002;47:364-70.
18. Trautinger F, Knobler R, Willemze R, Peris K, Stadler R, Laroche L et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome. Eur J Cancer 2006;42:1014-30.
19. Senff NJ, Noordijk EM, Kim YH, Bagot M, Berti E, Cerroni L et al. European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas. Blood 2008;112:1600-9.
20. Kempf W, Pfaltz K, Vermeer MH, Cozzio A, Ortiz-Romero PL, Bagot M et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood 2011;118:4024-35.
21. Olsen EA, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R et al. Revisions to the staging and classification of mycosis fungoides and Sézary Syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Study Group of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110:1713-22.
22. Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A et al. TNM Classification System for Primary Cutaneous Lymphomas Other Than Mycosis Fungoides and Sézary Syndrome. A Proposal of the International Society for Cutaneous Lymphomas (ISCL) and The Cutaneous Lymphoma Study Group of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007;110:479-484
23. Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR et al. International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol 2011-,29:2598-607.
24. Li JY, Horwitz S, Moskowitz A, Myskowski P, Pulitzer M, Querfeld C. Management of cutaneous T cell lymphoma: new and emerging targets and treatment options. Cancer Manag Res 2012;4:75-89.
25. Belloni B, Johansen N, Glass LF, Dummer R. Recent advances in the management of cutaneous lymphomas. Semin Oncol 2012;39:150-62.
26. Whittaker S. A cutaneous T-cell lymphoma EORTC trials platform. Clinical Lymphoma Myeloma and Leukemia 2010;10(Suppl)2:S90-S2.
27. Hoefnagel JJ, Dijkman R, Basso K, Jansen PM, Hallermann C, Willemze R et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 2005;105:3671-8.
28. Senff NJ, Zoutman WH, Vermeer MH, Assaf C, Berti E, Cerroni L et al. Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. J Invest Dermatol 2009; 129:1149-55.